Xiaolin Guo

Papers

Total Citations

121

H-Index

About

Xiaolin Guo is a leading figure in the advancement of minimally invasive urologic oncology, with a primary research focus on robotic surgery outcomes and evidence-based surgical comparisons. Dr. Guo’s major contributions lie in conducting rigorous systematic reviews and meta-analyses that critically evaluate the efficacy and safety of robotic-assisted techniques against traditional surgical approaches. Notably, their 2014 meta-analysis on robotic versus open radical cystectomy for bladder cancer, which has garnered 76 citations, provided pivotal evidence on perioperative outcomes and oncologic efficacy, helping to guide clinical decision-making in high-stakes cancer care. In a second highly cited work (45 citations), Dr. Guo systematically compared robot-assisted adrenalectomy to laparoscopic adrenalectomy, clarifying the benefits and limitations of robotic platforms in adrenal surgery. Through these landmark analyses, Dr. Guo has shaped the discourse on surgical innovation, offering clinicians and researchers a clear, data-driven perspective on the adoption of robotic technologies. Their work is essential reading for anyone studying the evolution of surgical oncology and the evidence base underpinning modern urologic practice.